SAB Biotherapeutics Approves Appointment of Andrew Moin to Board of Directors

SAB also announces closing of $7.5 million financing, the first tranche of $130 million private placementSIOUX FALLS, S.D., Oct. 05, 2023 -- SAB Biotherapeutics ; class='js-l-obf link...

Related Keywords

New York ,United States ,Andrew Moin ,Samuelj Reich ,Marshall Wace ,Company Board Of Directors ,Harvard Law School ,Rd Fund ,Amherst College ,Biotherapeutics Inc ,Exchange Commission ,Tax Group At Sullivan Cromwell ,Sessa Capital ,Young Leadership Committee ,New York City Chapter ,Tax Group ,Executive Chairman ,Commodore Capital ,Private Securities Litigation Reform Act ,Markets ,